If anybody ever wants to interview me about these five-stock samplers [you might be a journalist wondering whether people could pick stocks that do beat the market that consistently], I'll be the first to say, by the way, 100% is not a hit rate I will ever be able to maintain, but thinking back,
Industrial stocks may not get the same press or recognition as its consumer or tech brethren, but that doesn't mean there aren't great options for investors. In fact, some industrial companies have been generating returns for investors for over a century.
Big things usually have small beginnings. That's certainly the case with wind power in the United States. At the turn of the century wind farms contributed a negligible amount of electricity to the grid. But that changed as the technology and economics improved. Wind power's share of American el
You see, certain dividends are taxed at a much lower rate than other gains, thereby protecting a portion of your income. This is the case with qualified dividends – dividends earned from stocks you’ve held for at least 60 days before the ex-dividend date.
Instead of being taxed at the normal income rate, like short-term gains, qualified dividends are taxed at a significantly lower rate – up to nearly 50% less, depending on your tax bracket. With qualified dividends, you not only get reliable returns – you get to keep more while the tax man gets less.
If anybody ever wants to interview me about these five-stock samplers [you might be a journalist wondering whether people could pick stocks that do beat the market that consistently], I’ll be the first to say, by the way, 100% is not a hit rate I will ever be able to maintain, but thinking back, now, over three years, that is a pretty remarkable record of consistency. But whether or not we’re right 100% of the time or 75% or 50% of the time, what I really look at are the percentage points of alpha that would generate over and above the market, and that is a remarkable story. So,....More>>>
Despite recent volatility, you still hear a lot about the dominance of tech stocks. But what many don’t tell you is how uneven the run for stocks has been lately.
For instance, did you know that a handful of popular large-cap tech stocks like Apple Inc. (NASDAQ:AAPL) account for more than 10% of the S&P 500’s entire value? And did you know that, thanks to the recent underperformance of one-time darling Apple, most investors have suffered a drag on their portfolio even if they only own broad-based index funds?
Motley Fool co-founder David Gardner regularly recommends sets of stocks on the Rule Breaker Investing podcast — essentially giving us all a free taste of the choices he and his team make in Motley Fool Supernova’s portfolio universe. And he holds himself accountable, annually going back over those five-stock micro portfolios to let everyone see how he scored against the benchmark of the broader market.
Right now, it’s time for that yearly review of the ones he picked to honor the month, and also the briefly famous pregnant giraffe.
Let’s call a spade a spade. Turnaround stocks are fun. They’re even more fun when you’re able to say you bought them at — or at least near — their low because you understood the underlying story better than most other investors did.
While we’re being completely honest with ourselves though, let’s also admit that “buying on the dip” can often leave us battered, bruised and burned.
But slow and steady wins the race. Stocks that never really waver from their upward march can look and feel relatively expensive, making them tough....More>>>
Voyager Therapeutics Inc. (NASDAQ: VYGR) shares saw a handy gain on Tuesday after the company announced that it received some feedback from the U.S. Food and Drug Administration (FDA) from its Type C meeting.
Based on the written response from the FDA, Voyager continues to plan to submit
Alteryx, Inc.(NYSE:AYX) reported its first-quarter results on May 9, and the company saw its sales increase 50% year over year to $42.8 million. The data analytics platform specialist had a GAAP loss of $0.09 per share, compared to a loss of $0.22 per share in the year-ago quarter.
Wall Street brokerages expect E. W. Scripps (NYSE:SSP) to report sales of $275.05 million for the current quarter, according to Zacks. Three analysts have issued estimates for E. W. Scripps’ earnings, with the highest sales estimate coming in at $276.96 million and the lowest estimate comin